{"identifier":"nobleid:/w1/20260526/DF15744B","arkIdentifier":"ark:/48914/w1/20260526/DF15744B","version":1,"workTitle":"A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating the Safety and Activity of Pinatuzumab Vedotin (DCDT2980S) in Combination With Rituximab or Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab and a Non-Randomized Phase Ib/II Evaluation of Polatuzumab Vedotin in Combination With Obinutuzumab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma","workType":"Journal Article","authors":"Clinical Trials","description":null,"workUrl":null,"existingDoi":null,"createdAt":"2026-05-26T03:13:12.018575Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260526/DF15744B.v1"}